Colgate-Palmolive Company Financial Statements (CL)
|
|
Report date
|
|
|
30.06.2022 |
30.09.2022 |
31.12.2022 |
16.02.2023 |
15.02.2024 |
|
25.10.2024 |
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
|
|
17 967 |
17 967 |
19 457 |
|
20 106 |
Operating Income, bln rub |
|
|
|
|
3 614 |
4 335 |
3 984 |
|
4 519 |
EBITDA, bln rub |
? |
|
|
|
2 870 |
4 127 |
4 509 |
|
5 259 |
Net profit, bln rub |
? |
|
|
|
1 785 |
1 785 |
2 300 |
|
2 869 |
|
OCF, bln rub |
? |
|
|
|
2 556 |
2 556 |
3 745 |
|
3 974 |
CAPEX, bln rub |
? |
|
|
|
696.0 |
696.0 |
705.0 |
|
574.0 |
FCF, bln rub |
? |
|
|
|
1 860 |
1 860 |
3 040 |
|
3 400 |
Dividend payout, bln rub
|
|
|
|
|
1 691 |
1 556 |
1 749 |
|
1 611 |
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
Dividend payout ratio, %
|
|
|
|
|
94.7% |
87.2% |
76.0% |
|
56.2% |
|
OPEX, bln rub |
|
|
|
|
6 634 |
6 634 |
7 120 |
|
7 603 |
Cost of production, bln rub |
|
|
|
|
7 719 |
7 719 |
8 206 |
|
7 984 |
R&D, bln rub |
|
|
|
|
0.000 |
320.0 |
343.0 |
|
343.0 |
Interest expenses, bln rub |
|
|
|
|
153.0 |
167.0 |
287.0 |
|
236.0 |
|
Assets, bln rub |
|
|
15 711 |
16 288 |
15 731 |
15 731 |
16 393 |
|
16 774 |
Net Assets, bln rub |
? |
|
168.0 |
622.0 |
401.0 |
401.0 |
609.0 |
|
435.0 |
Debt, bln rub |
|
|
7 986 |
8 248 |
8 766 |
8 899 |
9 064 |
|
8 436 |
Cash, bln rub |
|
|
858.0 |
938.0 |
775.0 |
775.0 |
1 145 |
|
1 234 |
Net debt, bln rub |
|
|
7 128 |
7 310 |
7 991 |
8 124 |
7 919 |
|
7 202 |
|
Ordinary share price, rub |
|
|
80.1 |
70.3 |
78.8 |
78.8 |
79.7 |
|
74.8 |
Number of ordinary shares, mln |
|
|
|
|
836.4 |
836.4 |
827.4 |
|
817.7 |
|
Market cap, bln rub |
|
|
0 |
0 |
65 900 |
65 900 |
65 952 |
|
61 180 |
EV, bln rub |
? |
|
7 128 |
7 310 |
73 891 |
74 024 |
73 871 |
|
68 382 |
Book value, bln rub |
|
|
-5 384 |
-5 135 |
-4 871 |
-4 871 |
-4 688 |
|
-4 788 |
|
EPS, rub |
? |
|
|
|
2.13 |
2.13 |
2.78 |
|
3.51 |
FCF/share, rub |
|
|
|
|
2.22 |
2.22 |
3.67 |
|
4.16 |
BV/share, rub |
|
|
|
|
-5.82 |
-5.82 |
-5.67 |
|
-5.86 |
|
EBITDA margin, % |
? |
|
|
|
16.0% |
23.0% |
23.2% |
|
26.2% |
Net margin, % |
? |
|
|
|
9.93% |
9.93% |
11.8% |
|
14.3% |
FCF yield, % |
? |
|
0.00% |
0.00% |
2.82% |
2.82% |
4.61% |
|
5.56% |
ROE, % |
? |
|
0.00% |
0.00% |
445.1% |
445.1% |
377.7% |
|
659.5% |
ROA, % |
? |
|
0.00% |
0.00% |
11.3% |
11.3% |
14.0% |
|
17.1% |
|
P/E |
? |
|
|
|
36.9 |
36.9 |
28.7 |
|
21.3 |
P/FCF |
|
|
|
|
35.4 |
35.4 |
21.7 |
|
18.0 |
P/S |
? |
|
|
|
3.67 |
3.67 |
3.39 |
|
3.04 |
P/BV |
? |
|
0.00 |
0.00 |
-13.5 |
-13.5 |
-14.1 |
|
-12.8 |
EV/EBITDA |
? |
|
|
|
25.7 |
17.9 |
16.4 |
|
13.0 |
Debt/EBITDA |
|
|
|
|
2.78 |
1.97 |
1.76 |
|
1.37 |
|
R&D/CAPEX, % |
|
|
|
|
0.00% |
46.0% |
48.7% |
|
59.8% |
|
CAPEX/Revenue, % |
|
|
|
|
3.87% |
3.87% |
3.62% |
|
2.85% |
|
Colgate-Palmolive Company shareholders |